Editor-in-Chief

Alexander Sulakvelidze

Intralytix, Inc.
Baltimore, MD, US


Associate Editors

Stephen Abedon

Ohio State University
Mansfield, OH, US

Richard Calendar

University of California, Berkeley
Berleley, CA, US

Andrew Kropinski

PHA of Canada
Guelph, Ontario, CA

Elizabeth Kutter

Evergreen State College
Olympia, WA, US

Manan Sharma

Agricultural Research Service; United States Department of Agriculture
Beltsville, MD, US


Editorial Board

Hans Ackermann
Laval University
Quebec, QC, CA
Heather E. Allison
University of Liverpool
Liverpool, England, UK
Fumio Arisaka
Tokyo Institute of Technology
Yokohama, Kanagawa, JP
Paul Barrow
University of Nottingham
Loughsborough, Leicestershire, UK
Lindsay W. Black
University of Maryland
Baltimore, MD, US
Fidelma Boyd
University of Delaware
Newark, DE, US
Andy Brabban
Evergreen State College
Olympia, WA, US
Martha Clokie
University of Leicester
Leicester, England, UK
Bentley Fane
University of Arizona
Tucson, AZ, US
Vincent Fischetti
Rockefeller University
New York, NY, US
Ipek Goktepe
North Carolina A & T State Univeristy
Greensboro, NC, US
Lawrence Goodridge
Colorado State University
Fort Collins, CO, US
Paul Gulig
University of Florida
Gainsville, FL, US
Rob Lavigne
Katholieke Universiteit Leuven
Leuven, BE
Petr Leiman
Ecole Polytechnique Fédérale de Lausanne (EPFL)
Lausanne, CH
Martin Loessner
Swiss Federal Institute of Technology Zurich
Zurich, CH
Konstantin A. Miroshnikov
Russian Academy of Sciences
Moscow, RU
Glenn Morris
University of Florida
Gainesville, FL, US
Daniel Nelson
University of Maryland
Rockville, MD, US
Raul R. Raya
Centro de Referencia para Lactobacilos (CERELA-CONICET)
Tucuman, AR
Catherine Reese
University of Nottingham
Leicestershire, England, UK
David Schofield
Guild Associates, Inc.
Charleston, SC, US
Philip Serwer
The University of Texas Health Science Center
San Antonio, TX, US
Shanmuga Sozhamannan
Naval Medical Research Center
Ft. Detrick, MD, USA
Peter Stockley
University of Leeds
Leeds, England, UK


About the Editor-in-Chief

Dr. Alexander “Sandro” Sulakvelidze, Ph.D., is an Associate Professor of Molecular Genetics and Microbiology at the University of Florida College of Medicine, and Chief Scientist of Intralytix. Dr. Sulakvelidze is an internationally recognized expert in phage technology and infectious disease epidemiology. He has served/is serving as the Principal Investigator/Project Director of several grants and contracts from various agencies and foundations, including the National Institutes of Health (NIH), United States Department of Defense (DOD), United States Environmental Protection Agency (EPA), United States Department of Agriculture (USDA), National Food Processors Association (NFPA), Department of Health and Human Services Biotechnology Engagement Program (BTEP), and the Civilian Research and Development Foundation (CRDF). Dr. Sulakvelidze has published extensively on the subjects of molecular epidemiology and phage therapy, and he is the author of several issued and pending patents in the field of phage therapy. He also co-edited (with Dr. Elizabeth Kutter) a major book about bacteriophages, which was published by the CRC Press in 2005. Dr. Sulakvelidze’s phage research has been featured in several magazines and newspapers (including the Los Angeles Times, Newsweek, Science, Smithsonian and Wired), and in various radio programs and television documentaries (including National Public Radio’s Science Friday, BBC Radio and Voice of America radio programs, and BBC Horizon documentary about phage therapy). In addition to his service as Editor-in-Chief of Bacteriophage, Dr. Sulakvelidze serves as an ad hoc reviewer for (i) numerous journals, including Antimicrobial Agents and Chemotherapy, Applied and Environmental Microbiology, Drug Discovery Today, FEMS Immunology and Medical Microbiology, Clinical and Experimental Dermatology, Food Microbiology, Trends in Biotechnology, and Journal of Clinical Microbiology, and (ii) several funding agencies, including the CRDF, the International Science and Technology Center (ISTC), the U.S.-Israel Binational Science Foundation (BSF), and the NIH.

Advertisements